Jiabao Wang – Trademark Portfolio

Entity Type: 01

Jiabao Wang holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 25 (Clothing) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include UTCILS, VIFSSG, and NIUSISE. The owner is based in Yangchun, Guangdong.

No. 04, Xuer Village

Bajia Town Xuwu Village Committee

Yangchun, Guangdong 529634 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NIUSISE
NIUSISE
Registered 2025
UTCILS
UTCILS
Registered 2024
VIFSSG
VIFSSG
Registered 2022
SKYLER
SKYLER
Abandoned 2020

Trademark Classifications

Jiabao Wang's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Jiabao Wang have?

Jiabao Wang has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.

What trademark classes does Jiabao Wang file in?

Jiabao Wang files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Jiabao Wang's most well-known trademarks?

Jiabao Wang's registered trademark portfolio includes well-known marks such as UTCILS, VIFSSG, and NIUSISE. These are among 3 currently registered trademarks in the portfolio.

What is Jiabao Wang's trademark registration success rate?

Jiabao Wang has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.